ENG 12
- Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices (ENG)
- New Guidelines for Statistical Reporting in the Journal
- Considerations Regarding Non-Interventional Studies for Drug and Biological Products Guidance for Industry (ENG)
- From Statistical Significance to Significant Others
- New Year Greeting
- RWE guideline causal inference part2 (ENG)
- RWE guideline causal inference part1 (ENG)
- Steps to avoid over use and misuse of ML in clinical research Review
- DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a RCT_Review
- Comment on Framework for FDA's Real-World Evidence Program - part 2 (ENG)
- Comment on Framework for FDA's Real-World Evidence Program - part 1 (ENG)
- Switching noninferiority and superiority trial (ENG)